Back

Empagliflozin and dapagliflozin increase Na current in human cardiomyocytes

27 August 2022 (17:15 - 18:00)
Organised by:
Congress Presentation Part of: Mechanisms of ventricular arrhythmias Ion Channels, Electrophysiology ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Ricardo Caballero

Complutense University of Madrid, Madrid (Spain)

7 More presentations in this session

Presentation thumbnail
Synapsin 2 regulates NCX1 trafficking and is down-regulated in the failing myocardium, which increases the risk of ventricular arrhythmia and heart failure mortality
Doctor A. Ottesen (Nordbyhagen, NO)
Abstract Slides
Presentation thumbnail
Empagliflozin attenuates arrhythmogenesis via inhibition of O-GlcNAcylation in diastolic phase of diabetic cardiomyopathy.
Doctor T. Kadosaka (Sapporo, JP)
Abstract Slides
Presentation thumbnail
Disease-associated calmodulin mutations disrupt L-type Ca2+ channel (Cav1.2) activity and CaMKIIdelta phosphorylation in long QT syndrome
Assistant Professor N. Helassa (Liverpool, GB)
Abstract Slides
Presentation thumbnail
Long QT syndrome-associated calmodulin mutations and their interactions with the Kv7.1 voltage-gated potassium channel
Mr L. McCormick (Leeds, GB)
Abstract Slides
Presentation thumbnail
Utility of in vivo zebrafish cardiac assay to predict the functional impact of KCNQ1 variants
Mr S. Cui (Kanazawa, JP)
Abstract Slides

Access the full session

Session thumbnail
Mechanisms of ventricular arrhythmias

The Event

Event poster

ESC Congress 2022

27 August 2022 17:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources